Clinical outcome of sequential chemotherapy after immune checkpoint inhibitors in advanced ovarian cancer.

Luisa Bonilla,Amit M. Oza,Stephanie Lheureux,Sam Saibil,Shiyi Chen,Yeh Chen Lee,Diana Gray,Ilaria Colombo,Ainhoa Madariaga,Neesha C. Dhani,Gita Bhat,Valerie Bowering,Swati Garg,Daniel Yokom,Sunu Lazar Cyriac,Marcus O. Butler

Clinical outcome of sequential chemotherapy after immune checkpoint inhibitors in advanced ovarian cancer.

2019

Luisa Bonilla
Amit M. Oza
Stephanie Lheureux
Sam Saibil
Shiyi Chen
Yeh Chen Lee
Diana Gray
Ilaria Colombo
Ainhoa Madariaga
Neesha C. Dhani
Gita Bhat
Valerie Bowering
Swati Garg
Daniel Yokom
Sunu Lazar Cyriac
Marcus O. Butler

5580Background: Immunomodulation through check point inhibition is an important treatment strategy in many cancers. In ovarian cancer (OC) response rates with immune checkpoint inhibitors (ICI) alo...

Keywords:

Ovarian cancer
Immune checkpoint
Internal medicine
Pathology
Oncology
Medicine
Chemotherapy
advanced ovarian cancer
sequential chemotherapy
check point
treatment strategy
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations